Australia To Address Supply Chain Issues In Medicines Access Review

Policy May Be Extended To Vaccines & Devices

Stakeholders are being asked to say what they think of plans to future-proof the framework that governs access to medicines and is intended to help bolster the pharmaceutical sector.

Portrait of Nellie Melba on one hundred australian dollars note
Australia wants to maximize medicines access and value for money • Source: Shutterstock

The Australian health department is inviting comments on its plans to overhaul the National Medicines Policy and bring it up to date with developments such as new treatment options, advances in digital technology, and greater patient expectations.

The review of the NMP, which will be led by an expert committee headed by deputy chief medical officer Michael Kidd, was announced last month with the aim of making...

More from Market Access

More from Pink Sheet

EU To Track Decentralized Clinical Trials In CTIS To Support Innovation

 
• By 

Monitoring the use of decentralized elements in clinical trials is a priority for the European medicines regulatory network.

Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A

 

Pfizer told the Pink Sheet it would work with the health technology assessment institute, NICE, with the hope of making Hympavzi available to patients with hemophilia A via the National Health Service.

Autolus’s Aucatzyl And GSK’s Blenrep Among 10 New Drugs To Get EMA Nod

 
• By 

The European Medicines Agency has OKd 10 new medicines for EU-wide approval, including a CAR-T therapy for treating acute lymphoblastic leukemia. Two drugs were, however, rejected.